Quantcast
Home > Quotes > ARVN

Arvinas, Inc. Common Stock (ARVN) Quote & Summary Data

ARVN 
$17.63
*  
0.42
2.44%
Get ARVN Alerts
*Delayed - data as of Nov. 20, 2018  -  Find a broker to begin trading ARVN now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    ARVN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 6 / N/A
1 Year Target
22
Today's High / Low
$ 17.72 / $ 16.04
Share Volume
17,468
50 Day Avg. Daily Volume
N/A
Previous Close
$ 17.21
52 Week High / Low
$ 21.25 / $ 13.70
Market Cap
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
17,468
50 Day Avg. Daily Volume:
N/A

Trading Range

The current last sale of $17.63 is 28.69% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 17.72 $ 21.25
 Low: $ 16.04 $ 13.70

Company Description (as filed with the SEC)

We are a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins. We use our proprietary technology platform to engineer proteolysis targeting chimeras, or PROTACs, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. We believe that our targeted protein degradation approach is a new therapeutic modality that may provide distinct advantages over existing modalities, including traditional small molecule therapies and gene-based medicines.  ... More ...  


Risk Grade

Where does ARVN fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 17
Open Date:
Nov. 20, 2018
Close Price:
$ 17.21
Close Date:
Nov. 19, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x